Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

RBMXL1 Inhibitors

RBMXL1 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RBMXL1, a protein belonging to the RNA-binding motif protein family. RBMXL1, also known as hnRNPG-T, is involved in the regulation of pre-mRNA splicing, a critical process in gene expression. This protein plays an important role in modulating alternative splicing, which allows a single gene to produce multiple protein variants by selectively including or excluding certain exons during mRNA processing. RBMXL1 contains RNA recognition motifs (RRMs) that enable it to bind to specific RNA sequences and regulate the splicing machinery. Inhibitors of RBMXL1 work by binding to the protein's RNA-binding domains or interfering with its interactions with other components of the splicing machinery, thereby disrupting its role in alternative splicing.

The inhibition of RBMXL1 can lead to alterations in the splicing patterns of various pre-mRNAs, affecting the diversity of proteins produced by a cell. Since RBMXL1 is involved in regulating splicing in specific tissues, particularly in the testes and during spermatogenesis, the inhibition of this protein can result in significant changes in gene expression related to these processes. Researchers use RBMXL1 inhibitors to study the functional role of this protein in the regulation of alternative splicing and how it contributes to tissue-specific gene expression. These inhibitors provide valuable insights into the broader mechanisms of splicing regulation, helping scientists understand the complex networks of RNA-binding proteins that control mRNA processing. Additionally, RBMXL1 inhibitors allow for the exploration of how defects in splicing regulation can impact cellular function and development, shedding light on the intricate relationships between RNA-binding proteins and gene expression in different biological contexts. Through the study of these inhibitors, researchers can advance their knowledge of the molecular pathways involved in RNA splicing and post-transcriptional gene regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

A spliceosome inhibitor that could indirectly affect RBMXL1 function by altering splicing machinery.

Cdc2-Like Kinase Inhibitor, TG003

300801-52-9sc-202528
sc-202528A
5 mg
25 mg
$139.00
$548.00
6
(0)

A CLK kinase inhibitor affecting splicing regulation, potentially modulating RBMXL1 activity.

SRPIN 340

218156-96-8sc-394310
10 mg
$226.00
1
(1)

A specific inhibitor of SR protein kinase, which could indirectly influence RBMXL1 by altering splicing factor phosphorylation.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Known for its autophagy inhibition properties, it might indirectly influence RBMXL1 expression or stability.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

A BET bromodomain inhibitor that could indirectly affect gene expression, potentially influencing RBMXL1 levels.

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

A BET inhibitor, like JQ1, potentially modulating the expression of genes involved in RNA processing, including RBMXL1.